ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 180 filers reported holding ASCENDIS PHARMA A/S in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,998,000 | -22.7% | 15,500 | 0.0% | 0.02% | -30.0% |
| Q4 2020 | $2,585,000 | +8.1% | 15,500 | 0.0% | 0.03% | -9.1% |
| Q3 2020 | $2,392,000 | +21.6% | 15,500 | +16.5% | 0.03% | +17.9% |
| Q2 2020 | $1,967,000 | +46.8% | 13,300 | +11.8% | 0.03% | +7.7% |
| Q1 2020 | $1,340,000 | +2.3% | 11,900 | -12.5% | 0.03% | +8.3% |
| Q3 2019 | $1,310,000 | -37.5% | 13,600 | -25.3% | 0.02% | -33.3% |
| Q2 2019 | $2,096,000 | -2.1% | 18,200 | 0.0% | 0.04% | -69.5% |
| Q1 2019 | $2,142,000 | – | 18,200 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |